Cooke & Bieler LP reduced its stake in shares of H.B. Fuller (NYSE:FUL – Get Rating) by 12.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 691,174 shares of the specialty chemicals company's stock after selling 99,919 shares during the period. Cooke & Bieler LP's holdings in H.B. Fuller were worth $41,616,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. Mutual of America Capital Management LLC lifted its holdings in shares of H.B. Fuller by 6.0% during the 1st quarter. Mutual of America Capital Management LLC now owns 7,613 shares of the specialty chemicals company's stock worth $503,000 after acquiring an additional 434 shares during the period. Russell Investments Group Ltd. raised its holdings in H.B. Fuller by 40.5% in the first quarter. Russell Investments Group Ltd. now owns 5,598 shares of the specialty chemicals company's stock valued at $369,000 after buying an additional 1,613 shares during the period. State of Tennessee Treasury Department raised its holdings in H.B. Fuller by 9.6% in the first quarter. State of Tennessee Treasury Department now owns 34,110 shares of the specialty chemicals company's stock valued at $2,254,000 after buying an additional 2,997 shares during the period. MetLife Investment Management LLC raised its holdings in H.B. Fuller by 55.7% in the first quarter. MetLife Investment Management LLC now owns 27,833 shares of the specialty chemicals company's stock valued at $1,839,000 after buying an additional 9,960 shares during the period. Finally, Castleview Partners LLC purchased a new position in H.B. Fuller in the fourth quarter valued at approximately $127,000. 96.38% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, VP Nathan D. Weaver sold 5,988 shares of H.B. Fuller stock in a transaction that occurred on Monday, July 25th. The shares were sold at an average price of $62.82, for a total transaction of $376,166.16. Following the sale, the vice president now owns 3,766 shares in the company, valued at $236,580.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Trangsrud Teresa J. Rasmussen purchased 1,000 shares of the firm's stock in a transaction dated Tuesday, July 5th. The stock was acquired at an average price of $58.20 per share, with a total value of $58,200.00. Following the completion of the transaction, the director now owns 1,000 shares of the company's stock, valued at $58,200. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, VP Nathan D. Weaver sold 5,988 shares of the firm's stock in a transaction that occurred on Monday, July 25th. The stock was sold at an average price of $62.82, for a total transaction of $376,166.16. Following the sale, the vice president now directly owns 3,766 shares of the company's stock, valued at approximately $236,580.12. The disclosure for this sale can be found here. Insiders own 4.69% of the company's stock.

H.B. Fuller Trading Down 2.2 %

H.B. Fuller (NYSE:FUL – Get Rating) last posted its quarterly earnings data on Wednesday, September 21st. The specialty chemicals company reported $1.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.05 by $0.01. The company had revenue of $941.20 million for the quarter, compared to analyst estimates of $944.11 million. H.B. Fuller had a net margin of 5.33% and a return on equity of 13.89%. The business's quarterly revenue was up 13.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.79 earnings per share. Analysts expect that H.B. Fuller will post 4.2 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on FUL. Deutsche Bank Aktiengesellschaft cut their price target on shares of H.B. Fuller from $85.00 to $72.00 and set a "buy" rating on the stock in a report on Friday, June 24th. JPMorgan Chase & Co. lowered shares of H.B. Fuller from a "neutral" rating to an "underweight" rating and cut their price target for the company from $70.00 to $52.00 in a report on Friday, June 24th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $71.00.

H.B. Fuller Profile

(Get Rating)

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.

Featured Articles

• Get a free copy of the StockNews.com research report on H.B. Fuller (FUL)
• Declining Profits Challenge the CarMax Value Proposition
• Let Paychex Stock Work Hard For You
• How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
• Thor Industries Hammers Out A Bottom
• Humana Proves Vertically Integrated Healthcare Works

Want to see what other hedge funds are holding FUL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for H.B. Fuller (NYSE:FUL – Get Rating).

Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.